Dr Farnoush Noushi
MBBS, MS, PHD, FRACS
- General Surgery
- Breast Surgery
- Surgical Oncology
- Laparoscopic surgery
Dr Noushi is a Breast Oncoplastic Surgeon, Surgical Oncologist & General Surgeon with over 20 years of experience, based on the North Shore and Northern Beaches. Dr Noushi manages patients at Sydney Adventist Hospital, and also manages public and private patients at North Shore Private, Northern Beaches and Ryde hospitals.
As a Breast Surgeon Dr Noushi performs a wide range of breast oncological and reconstructive procedures, which include breast conserving surgery, sentinel lymph node biopsy, therapeutic mammoplasty, breast reduction, implant and tissue transfer breast reconstruction. As a Surgical Oncologist and General Surgeon, Dr Noushi has extensive surgical proficiency in laparoscopic hernia repair, gallbladder and gastrointestinal surgery including endoscopy/colonoscopy, skin cancer and soft tissue surgery. He is also a mentor to the next generation of surgeons and a surgical trainer at the Royal Australasian College of Surgeons.
Dr Noushi began his medical training at the University of Melbourne graduating with honours. He completed his FRACS in Melbourne and moved to Sydney in 2005 where he specialised in breast and oncology surgery at RPAH. Dr Noushi then undertook further training and research at the NSW Cancer Institute, Royal North Shore and Mater Hospitals. He was granted the Cancer Institute Fellowship Award, John Collins Gold Medal from the ANZBCTG and several travel and research grants for his pioneering work in sentinel lymph node biopsy. This research has been practice changing and Dr Noushi was awarded a Doctor of Philosophy (PhD) for his work.
Dr Noushi uses state of the art proven techniques in treating all of his patients, resulting in excellent health outcomes. His team is committed to providing high quality individualised care for all of his patients; focusing on patient comfort, education and well-being.
Dr Noushi has published works in breast and general surgery. He continues to be involved in breast cancer clinical trials.